Publications by authors named "Menghan Fang"

Article Synopsis
  • Gastric cancer (GC) has low survival rates and limited treatment options, often associated with mutations in the ARID1A gene, prompting the exploration of novel therapies.
  • Researchers screened 551 kinase inhibitors and found AZD5363 (an AKT inhibitor) to be the most effective in targeting ARID1A-deficient cancer cells by inducing synthetic lethality.
  • The mechanism involves AZD5363 causing pyroptotic cell death through the Caspase-3/GSDME pathway while also revealing that ARID1A normally represses AKT expression, explaining its increased activity in deficient cells.
View Article and Find Full Text PDF

Attributed to the characteristics of narrow band gap structural units and full spectral response, iso-indigo is often used as an electron acceptor in organic electronic materials. Organic molecules with large conjugated surfaces and strong intermolecular forces can form ordered stacked structures through self-assembly. In this paper, the self-assembly performances of IDCF and IDCN are regulated by changing the end groups.

View Article and Find Full Text PDF

Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) has been identified as a crucial immune suppressor in human cancers, comparable to programmed cell death 1 ligand (PD-L1). However, the regulatory mechanisms underlying its transcriptional upregulation in human cancers remain largely unknown. Here, we show that the transcription factors ETS-1 and ETS-2 bound to the Siglec-15 promoter to enhance transcription and expression of Siglec-15 in hepatocellular carcinoma (HCC) cells and that transforming growth factor β-1 (TGF-β1) upregulated the expression of ETS-1 and ETS-2 and facilitated the binding of ETS-1 and ETS-2 to the Siglec-15 promoter.

View Article and Find Full Text PDF

Koumine is an alkaloid that displays notable activity against inflammatory and neuropathic pain, but its therapeutic target and molecular mechanism still need further study. Translocator protein 18 kDa (TSPO) is a vital therapeutic target for pain treatment, and recent research implies that there may be allostery in TSPO. Our previous competitive binding assay hint that koumine may function as a TSPO positive allosteric modulator (PAM).

View Article and Find Full Text PDF

To examine the effect of koumine, a Gelsemium alkaloid, on two experimental models of rheumatoid arthritis (RA), rats with adjuvant-induced arthritis (AIA) and collagen-induced arthritis (CIA) were administered koumine (0.6, 3, or 15 mg/kg/day) or vehicle through gastric gavage (i.g.

View Article and Find Full Text PDF